Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z

Open source

DOI: 10.1001/jama.2017.18718
Published: 2017 Dec 19
Container: JAMA
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2017.18718,
  title = {Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.},
  author = {Stupp R and Taillibert S and Kanner A and Read W and Steinberg D and Lhermitte B and Toms S and Idbaih A and Ahluwalia MS and Fink K and Di Meco F and Lieberman F and Zhu JJ and Stragliotto G and Tran D and Brem S and Hottinger A and Kirson ED and Lavy-Shahaf G and Weinberg U and Kim CY and Paek SH and Nicholas G and Bruna J and Hirte H and Weller M and Palti Y and Hegi ME and Ram Z},
  year = {2017},
  journal = {JAMA},
  doi = {10.1001/jama.2017.18718},
  url = {https://doi.org/10.1001/jama.2017.18718}
}

RIS

TY  - JOUR
TI  - Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
AU  - Stupp R
AU  - Taillibert S
AU  - Kanner A
AU  - Read W
AU  - Steinberg D
AU  - Lhermitte B
AU  - Toms S
AU  - Idbaih A
AU  - Ahluwalia MS
AU  - Fink K
AU  - Di Meco F
AU  - Lieberman F
AU  - Zhu JJ
AU  - Stragliotto G
AU  - Tran D
AU  - Brem S
AU  - Hottinger A
AU  - Kirson ED
AU  - Lavy-Shahaf G
AU  - Weinberg U
AU  - Kim CY
AU  - Paek SH
AU  - Nicholas G
AU  - Bruna J
AU  - Hirte H
AU  - Weller M
AU  - Palti Y
AU  - Hegi ME
AU  - Ram Z
PY  - 2017
JO  - JAMA
DO  - 10.1001/jama.2017.18718
UR  - https://doi.org/10.1001/jama.2017.18718
ER  -

APA

R, S., S, T., A, K., W, R., D, S., B, L., S, T., A, I., MS, A., K, F., F, D. M., F, L., JJ, Z., G, S., D, T., S, B., A, H., ED, K., G, L., U, W., CY, K., SH, P., G, N., J, B., H, H., M, W., Y, P., ME, H., & Z, R. (2017). Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2017.18718

Source records

pubmed · retrieved 2026-09-26T22:07:07.403Z